⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17573449 | 0.73 | — | — | |
| SCHEMBL10014748 | 0.68 | — | — | |
| SCHEMBL22731179 | 0.68 | — | — | |
| SCHEMBL282507 | 0.68 | — | — | |
| SCHEMBL11046561 | 0.68 | LMNA (0.30) | — | |
| SCHEMBL7953133 | 0.68 | LMNA (0.30) | — | |
| Hydrochloric Acid SCHEMBL25253221 | 0.57 | — | — | |
| Hydrochloric Acid SCHEMBL31152128 | 0.57 | — | — | |
| SCHEMBL371264 | 0.54 | — | — | |
| SCHEMBL8278037 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747261-A1 | AMINOPYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS | Accutar Biotechnology Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20250346593-A1 | IMIDAZO(1,2-1)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | INTERLINE THERAPEUTICS INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12338248-B2 | Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors | ACCUTAR BIOTECHNOLOGY INC. (US) | 2025-06-24 | — | — | US | disclosed |
| CN-119698416-A | Imidazo (1, 2-A) pyridine derivatives as RIPK2 inhibitors | 英特莱治疗公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4518974-A1 | IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | Interline Therapeutics, Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| WO-2025024388-A1 | AMINOPYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS | ACCUTAR BIOTECHNOLOGY INC. (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2023239941-A1 | IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | INTERLINE THERAPEUTICS INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| EP-4113898-A1 | METHOD AND SYSTEM FOR AUTHENTICATING, BY VERIFICATION EQUIPMENT, A DEVICE TO BE AUTHENTICATED PROVIDED WITH A PUF CIRCUIT | Electricité de France (FR) | 2023-01-04 | — | — | EP | disclosed |
| US-6311516-B1 | SEPARATING GAS STREAM CONTAINING METHANE AND HYDROCARBON GASES INTO VOLATILE AND NONVOLATILE FRACTIONS; COOL FEED GAS, SEPARATE VAPORS, REPEAT PROCESS FOR RECOVERED GASES AND LIQUIDS | LINDE ENGINEERING NORTH AMERICA INC. | 2001-11-06 | — | — | US | disclosed |